Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]AH-111585 PET Imaging for Tumor Detection
NCT00565721Phase 2Completed
- Sponsor
- GE HealthCare
- Start
- Nov 2007
- Primary completion
- Oct 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclatide in glioma, lung cancer, head and neck cancer (HNC), sarcoma, melanoma, sponsored by GE HealthCare. Started Nov 2007; status: completed.
02
Drugs
fluciclatide
03
Conditions
gliomalung cancerhead and neck cancer (HNC)sarcomamelanoma
Beyond the preview
Go deeper on NCT00565721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565721.